NLM Logo

Neuraminidase deficiency with beta-galactosidase deficiency MeSH Supplementary Concept Data 2024


MeSH Supplementary
Neuraminidase deficiency with beta-galactosidase deficiency
Unique ID
C536411
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C536411
Entry Term(s)
Cathepsin A Deficiency
Cathepsin A, deficiency of
Deficiency of Cathepsin A
Galactosialidosis
Goldberg syndrome
Lysosomal Protective Protein Deficiency
Lysosomal protective protein, deficiency of
Protective protein-Cathepsin A deficiency
Registry Number
0
Heading Mapped to
*Lysosomal Storage Diseases
Frequency
25
Note
A hereditary autosomal recessive lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in protective protein/cathepsin A (PPCA). All patients have clinical manifestations typical of a lysosomal disorder, such as coarse FACIES, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated LYMPHOCYTES. Three phenotypic subtypes are recognized. The early infantile form is associated with HYDROPS FETALIS; EDEMA; ASCITES, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and rare occurrence of neurologic signs. The juvenile/adult form is characterized by MYOCLONUS; ATAXIA; ANGIOKERATOMA; INTELLECTUAL DISABILITY, neurologic deterioration, absence of visceromegaly, and long survival. The majority of reported patients belong to the juvenile/adult group and are mainly of Japanese origin. Mutations in the CTSA gene have been identified. OMIM: 256540
Date of Entry
2010/08/25
Revision Date
2015/09/27
Neuraminidase deficiency with beta-galactosidase deficiency Preferred
page delivered in 0.007s